Available by prescription, this device is designed to offer pain relief via transcutaneous electrical nerve stimulation (TENS) therapy. Founded in 1996, Zynex has been developing, manufacturing ...
The US Food and Drug Administration (FDA) has approved medical technology company Zynex’s next-generation neuromuscular electrical stimulation (NMES) device, the M-Wave. This device is intended ...
Zynex (ZYXI) announced highlights from a recent study comparing its NiCO laser pulse oximeter to conventional LED pulse oximeters for the effects of skin pigmentation on SpO2 measurements. Zynex’s ...
Zynex (ZYXI) has completed its clinical verification trial for their NiCO pulse oximeter overseen by anesthesiologist Dr. David MacLeod at Duke University. Trial completion is a key milestone ...
ENGLEWOOD, Colo., Dec. 3, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company ...
ENGLEWOOD, Colo., Dec. 5, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company ...